Mr. Utkhede has 22 years of experience in pharmaceutical formulation and process development and has extensive experience developing robust and commercially scalable manufacturing processes. He has worked extensively developing various pharmaceutical dosage forms — topicals (dermal and ocular), orals (capsules and liquid), parenterals (aseptic and terminally sterilized) — and drug/device combination products with extensive experience in the area of lyophilization, liposome and emulsion technology. Utkhede is also well versed in GMP/FDA regulation.
Mr. Utkhede is the COO of Vantage Hemp Co., with 22 years’ experience in pharmaceutical formulation and development. A specialist in lyophilization, liposome and emulsion technology, he has worked extensively in the production of pharmaceutical-grade cannabinoid treatments – including oils, topicals and isolates. Utkhede’s background in the healthcare industry, designing robust and commercially scalable manufacturing processes, has been pivotal to Vantage Hemp securing GMP and EU compliance as the company expands worldwide.
